Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Kymera Therapeutics Inc (NASDAQ: KYMR) closed the day trading at $33.35 down -5.28% from the previous closing price of $35.21. In other words, the price has decreased by -$5.28 from its previous closing price. On the day, 0.79 million shares were traded. KYMR stock price reached its highest trading level at $34.29 during the session, while it also had its lowest trading level at $32.75.
Ratios:
For a better understanding of KYMR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.73 and its Current Ratio is at 4.73. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on April 22, 2024, initiated with a Outperform rating and assigned the stock a target price of $53.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 15 ’24 when Booth Bruce sold 71,764 shares for $40.46 per share. The transaction valued at 2,903,336 led to the insider holds 806,697 shares of the business.
Booth Bruce sold 55,779 shares of KYMR for $2,229,927 on Mar 14 ’24. The Director now owns 819,151 shares after completing the transaction at $39.98 per share. On Mar 13 ’24, another insider, Booth Bruce, who serves as the Director of the company, sold 139,255 shares for $42.23 each. As a result, the insider received 5,880,415 and left with 828,830 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2038075136 and an Enterprise Value of 1747867520. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.93 while its Price-to-Book (P/B) ratio in mrq is 4.69. Its current Enterprise Value per Revenue stands at 22.24 whereas that against EBITDA is -10.693.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $45.31, while it has fallen to a 52-week low of $9.60. The 50-Day Moving Average of the stock is -14.40%, while the 200-Day Moving Average is calculated to be 30.60%.
Shares Statistics:
Over the past 3-months, KYMR traded about 652.76K shares per day on average, while over the past 10 days, KYMR traded about 532010 shares per day. A total of 55.59M shares are outstanding, with a floating share count of 54.16M. Insiders hold about 11.38% of the company’s shares, while institutions hold 90.18% stake in the company. Shares short for KYMR as of 1713139200 were 9700125 with a Short Ratio of 14.86, compared to 1710460800 on 8326914. Therefore, it implies a Short% of Shares Outstanding of 9700125 and a Short% of Float of 17.790001999999998.
